✦ LIBER ✦

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

✍ Scribed by Myron S. Czuczman; Julie M. Vose; Thomas E. Witzig; Pier L. Zinzani; Rena Buckstein; Jonathan Polikoff; Ju Li; Dennis Pietronigro; Annetti Ervin-Haynes; Craig B. Reeder

Book ID: 108677357
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 109 KB
Volume: 154
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08781.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of the oral mammalian targ

Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma

✍ Kensei Tobinai; Michinori Ogura; Dai Maruyama; Toshiki Uchida; Naokuni Uike; Ils 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 345 KB

Equitoxicity of bolus and infusional eto

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

✍ Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 259 KB

Gemcitabine, dexamethasone, and cisplati

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma : A Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

✍ Michael Crump; Tara Baetz; Stephen Couban; Andrew Belch; Deborah Marcellus; Kang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views